Literature DB >> 30316008

Inflammasome activation and regulation during Helicobacter pylori pathogenesis.

Sandeep Kumar1, Monisha Dhiman2.   

Abstract

Helicobacter pylori is a leading cause of gastric cancer worldwide, its type four secretary toxin CagA is cited to be primarily responsible for it. Other virulence factors such as urease, VacA, HopQ, BabA and SabA are responsible for bacterial survival in acidic environment, adherence and cellular damage but its molecular mechanism is not completely understood. A number of pathogens including bacteria, fungi and virus are involved in the regulation of cellular machinery of inflammasome. Inflammasomes are multimeric protein complexes formed after external stimuli such as PAMPs/DAMPs or salt crystals and activates cellular caspases causes inflammation via pro-inflammatory cytokines. Virulence factors associated with microbial pathogens causes' cellular damage through damaging mitochondria, rupturing lysosome, producing endoplasmic stress and dysregulation of cellular ions balance. These cellular dysfunctioning leads to oxidative stress, cathepsin B production, nuclear and mitochondrial DNA damage which activates inflammasome machinery, pro-inflammatory cytokine release and cellular death known as pyroptosis. The mechanism of inflammasome induction by H. pylori is not studied extensively and very few virulence factors such as UreB, CagA, FlaA and VacA and their role in inflammasomes is established. This review elaborates the mechanism of inflammasomes regulation and elucidates the pathways through which H. pylori regulates inflammasome activation.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Caspases; Helicobacter pylori; IL-1β; Inflammasome; Virulence factors

Mesh:

Substances:

Year:  2018        PMID: 30316008     DOI: 10.1016/j.micpath.2018.10.012

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  9 in total

1.  Association of Progranulin Gene Expression from Dyspeptic Patients with Virulent Helicobacter pylori Strains; In Vivo Model.

Authors:  Claudia Troncoso; Mónica Pavez; Álvaro Cerda; Victor Manríquez; Aurora Prado; Edmundo Hofmann; Eddy Ríos; Armando Sierralta; Luis Copelli; Leticia Barrientos
Journal:  Microorganisms       Date:  2022-05-10

2.  The Influence of IL-1B Gene Polymorphisms on H. pylori Infection and Triple Treatment Response Among Jordanian Population.

Authors:  Muhamad Ali K Shakhatreh; Omar F Khabour; Karem H Alzoubi; Mohammed N BaniHani; Ahmed Abu-Siniyeh; Nabil A Bashir; Salsabeel H Sabi; Mahmoud Mahafdah
Journal:  Appl Clin Genet       Date:  2020-07-02

Review 3.  Molecular mechanism of Helicobacter pylori-induced autophagy in gastric cancer.

Authors:  Fan Zhang; Cong Chen; Jike Hu; Ruiliang Su; Junqiang Zhang; Zhijian Han; Hao Chen; Yumin Li
Journal:  Oncol Lett       Date:  2019-10-10       Impact factor: 2.967

4.  Effects of Multi-Strain Probiotics on Immune Responses and Metabolic Balance in Helicobacter pylori-Infected Mice.

Authors:  Chun-Che Lin; Wei-Chiao Huang; Chiu-Hsian Su; Wei-De Lin; Wen-Tzu Wu; Bi Yu; Yuan-Man Hsu
Journal:  Nutrients       Date:  2020-08-17       Impact factor: 5.717

Review 5.  Helicobacter pylori and gastric cancer: a lysosomal protease perspective.

Authors:  Surinder M Soond; Andrey A Zamyatnin
Journal:  Gastric Cancer       Date:  2021-12-16       Impact factor: 7.370

Review 6.  An Overview of Autophagy in Helicobacter pylori Infection and Related Gastric Cancer.

Authors:  Yihan Yang; Xu Shu; Chuan Xie
Journal:  Front Cell Infect Microbiol       Date:  2022-04-08       Impact factor: 6.073

7.  Nanomechanical Hallmarks of Helicobacter pylori Infection in Pediatric Patients.

Authors:  Piotr Deptuła; Łukasz Suprewicz; Tamara Daniluk; Andrzej Namiot; Sylwia Joanna Chmielewska; Urszula Daniluk; Dariusz Lebensztejn; Robert Bucki
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

8.  Anti-Helicobacter pylori treatment can effectively improve the clinical remission rates of irritable bowel syndrome: a controlled clinical trial meta-analysis.

Authors:  Yan Xiong; Lulu Liu; Xuchun Zhou; Youfei Wen; Ruonan Wang
Journal:  Clinics (Sao Paulo)       Date:  2020-11-11       Impact factor: 2.365

Review 9.  Interplays between inflammasomes and viruses, bacteria (pathogenic and probiotic), yeasts and parasites.

Authors:  Hanna Antushevich
Journal:  Immunol Lett       Date:  2020-09-22       Impact factor: 3.685

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.